TABLE 5.
Univariate analysis of cancer‐specific survival
| Variables | Subgroups | HR | 95.0% CI for HR | p value | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Sex | Male | Reference | |||
| Female | 1.150 | 0.941 | 1.405 | 0.172 | |
| Race | White | Reference | 0.322 | ||
| Black | 1.260 | 0.929 | 1.709 | 0.137 | |
| Other | 0.971 | 0.632 | 1.491 | 0.893 | |
| Histology | Nonurothelium carcinoma | Reference | |||
| Urothelium carcinoma | 0.693 | 0.489 | 0.983 | 0.040 | |
| Age | <60 | Reference | <0.001 | ||
| 60–69 | 1.126 | 0.776 | 1.633 | 0.532 | |
| 70–79 | 1.174 | 0.825 | 1.671 | 0.374 | |
| ≥80 | 1.750 | 1.238 | 2.473 | 0.002 | |
| T | T2 | Reference | <0.001 | ||
| T3 | 1.350 | 0.994 | 1.834 | 0.055 | |
| T4 | 2.355 | 1.741 | 3.187 | <0.001 | |
| Grade | Well/moderately differentiated | Reference | 0.596 | ||
| Poorly differentiated | 1.046 | 0.610 | 1.794 | 0.870 | |
| Undifferentiated | 0.937 | 0.559 | 1.572 | 0.806 | |
Abbreviations: CI, confidence interval; HR, hazard ratio.